<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:48:22Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3642165" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3642165</identifier><datestamp>2013-05-06</datestamp><setSpec>febsopenbio</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">FEBS Open Bio</journal-id>
      <journal-id journal-id-type="iso-abbrev">FEBS Open Bio</journal-id>
      <journal-title-group>
        <journal-title>FEBS Open Bio</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2211-5463</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3642165</article-id>
      <article-id pub-id-type="pmcid">PMC3642165</article-id>
      <article-id pub-id-type="pmc-uid">3642165</article-id>
      <article-id pub-id-type="pmid">23650607</article-id>
      <article-id pub-id-type="publisher-id">FOB44</article-id>
      <article-id pub-id-type="doi">10.1016/j.fob.2012.08.005</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tespa1 is a novel inositol 1,4,5-trisphosphate receptor binding protein in T and B lymphocytes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Matsuzaki</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">a</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fujimoto</surname>
            <given-names>Takahiro</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">a</xref>
          <xref rid="aff0002" ref-type="aff">b</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ota</surname>
            <given-names>Takeharu</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ogawa</surname>
            <given-names>Masahiro</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsunoda</surname>
            <given-names>Toshiyuki</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">a</xref>
          <xref rid="aff0002" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Doi</surname>
            <given-names>Keiko</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">a</xref>
          <xref rid="aff0002" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hamabashiri</surname>
            <given-names>Masato</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanaka</surname>
            <given-names>Masatoshi</given-names>
          </name>
          <xref rid="aff0003" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shirasawa</surname>
            <given-names>Senji</given-names>
          </name>
          <email>sshirasa@fukuoka-u.ac.jp</email>
          <xref rid="aff0001" ref-type="aff">a</xref>
          <xref rid="aff0002" ref-type="aff">b</xref>
          <xref rid="cor0001" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="aff0001"><label>a</label>Department of Cell Biology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan</aff>
      <aff id="aff0002"><label>b</label>Central Research Institute for Advanced Molecular Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan</aff>
      <aff id="aff0003"><label>c</label>Department of Urology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan</aff>
      <author-notes>
        <corresp id="cor0001"><label>*</label>Corresponding author at: Department of Cell Biology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan. Tel.: +81 92 801 1011; fax: +81 92 864 3865. <email>sshirasa@fukuoka-u.ac.jp</email></corresp>
        <fn id="fn1">
          <label>1</label>
          <p>Authors with equal contributions to the work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date pub-type="epub">.-->
      <pub-date pub-type="epub">
        <day>4</day>
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <volume>2</volume>
      <fpage>255</fpage>
      <lpage>259</lpage>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>7</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>30</day>
          <month>7</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>8</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2012 Published by Elsevier B.V. on behalf of Federation of European Biochemical Societies.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Federation of European Biochemical Societies</copyright-holder>
        <license>
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Tespa1 has been recently reported to be a critical molecule in T-cell development, however, the precise molecular mechanisms of Tespa1 remain elusive. Here, we demonstrate that Tespa1 shows amino-acid sequence homology to <italic>KRAS</italic>-induced actin-interacting protein (KRAP), an inositol 1,4,5-trisphosphate receptor (IP<sub>3</sub>R) binding protein, and that Tespa1 physically associates with IP<sub>3</sub>R in T and B lymphocytes. Two-consecutive phenylalanine residues (Phe185/Phe186) in Tespa1, which are conserved between Tespa1 and KRAP, are indispensable for the association between Tespa1 and IP<sub>3</sub>R. These findings suggest that Tespa1 plays critical roles in the immune system through the regulation of the IP<sub>3</sub>R.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Highlights</title>
        <p>â¸ We identified Tespa1 as a novel IP<sub>3</sub>R-associated protein in lymphoid tissues. â¸ Tespa1 interacts with multiple subtypes of IP<sub>3</sub>R in T and B lymphocytes. â¸ Amino-terminal region of IP<sub>3</sub>R is sufficient for the association with Tespa1. â¸ Two consecutive phenylalanines in Tespa1 are critical for the interaction with IP<sub>3</sub>R. â¸ Tespa1 is structurally and functionally related to KRAP.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Tespa1</kwd>
        <kwd>IP<sub>3</sub>R</kwd>
        <kwd>Proteinâprotein interaction</kwd>
        <kwd>Thymus</kwd>
        <kwd>Spleen</kwd>
        <kwd>Lymphocyte</kwd>
      </kwd-group>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>Tespa1, thymocyte-expressed positive selection-associated 1</kwd>
        <kwd>IP<sub>3</sub>R, Inositol 1,4,5-trisphosphate receptor</kwd>
        <kwd>KRAP, <italic>KRAS</italic>-induced actin-interacting protein.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec0001">
      <label>1</label>
      <title>Introduction</title>
      <p>Intracellular Ca<sup>2+</sup> is a versatile, universal second messenger controlling numerous biological processes [<xref rid="bib1" ref-type="bibr">1</xref>,<xref rid="bib2" ref-type="bibr">2</xref>]. Three inositol 1,4,5-trisphosphate receptor (IP<sub>3</sub>R) subtypes are differentially expressed among tissues [<xref rid="bib3 bib4 bib5 bib6 bib7" ref-type="bibr">3â7</xref>] and function as the Ca<sup>2+</sup> release channel on endoplasmic reticulum membranes [<xref rid="bib8 bib9 bib10 bib11 bib12" ref-type="bibr">8â12</xref>]. IP<sub>3</sub>R is regulated by many intracellular modulators, phosphorylation by kinases, and associated proteins [<xref rid="bib13 bib14 bib15 bib16 bib17" ref-type="bibr">13â17</xref>].</p>
      <p><italic>KRAS</italic>-induced actin-interacting protein (KRAP), originally identified as one of the deregulated expression genes in colorectal cancer [<xref rid="bib18" ref-type="bibr">18</xref>] and also known as sperm-specific antigen 2 (SSFA2), physiologically participates in the regulation of systemic energy homeostasis [<xref rid="bib19" ref-type="bibr">19</xref>] and of the exocrine system [<xref rid="bib20" ref-type="bibr">20</xref>]. We have recently demonstrated that KRAP is involved in the regulation of the proper localization and function of IP<sub>3</sub>R through the physical molecular interaction in the epithelial cells [<xref rid="bib21 bib22 bib23" ref-type="bibr">21â23</xref>]. On the other hand, <italic>Tespa1</italic> (thymocyte-expressed positive selection-associated 1) has just recently been reported to play a crucial role in T-cell development in the thymus [<xref rid="bib24" ref-type="bibr">24</xref>], however, the precise molecular mechanisms of Tespa1 remain elusive.</p>
      <p>We herein report that Tespa1 possesses substantial amino acid sequence homology to KRAP. Tespa1 is exclusively expressed in T and B lymphocytes and is functionally related to KRAP; Tespa1 physically interacts with IP<sub>3</sub>R in T and B lymphocytes. Thus, our finding that IP<sub>3</sub>R is directly regulated by Tespa1 provides insight into the molecular mechanism underlying the regulation of IP<sub>3</sub>R in T and B lymphocytes.</p>
    </sec>
    <sec sec-type="materials|methods" id="sec0002">
      <label>2</label>
      <title>Materials and methods</title>
      <sec id="sec0003">
        <label>2.1</label>
        <title>Antibodies</title>
        <p>The antibodies used were as follows: anti-actin (A2066) from Sigma, anti-hemagglutinin (HA) (3F10) from Roche, anti-green fluorescent protein (GFP) (632460) from Clontech, anti-IP<sub>3</sub>R1 (ab5840) from Abcam, anti-IP<sub>3</sub>R3 (610313) from BD Transduction Laboratories, anti-ERK (K-23) from Santa Cruz Biotechnology, and anti-ATP synthase (3D5) from Abcam. The recombinant human Tespa1 fragment (amino acid residues 2â182) was expressed as a GST fusion protein using the pGEX4T-2 vector (GE Healthcare). The fusion protein was soluble in nondenaturing buffer and was purified with glutathione-Sepharose 4B (Amersham Pharmacia). Antiserum was obtained by injecting the recombinant Tespa1 protein into a Japanese White rabbit followed by booster injection. Antiserum was purified with an affinity column prepared by cross-linking the recombinant protein to CNBr-activated Sepharose 4B (Amersham Pharmacia).</p>
      </sec>
      <sec id="sec0004">
        <label>2.2</label>
        <title>Animals</title>
        <p>All animals used in this study were treated in accordance with the guidelines of Fukuoka University.</p>
      </sec>
      <sec id="sec0005">
        <label>2.3</label>
        <title>Cell isolation and subcellular fractionation</title>
        <p>Positive selection of a specific type of lymphocyte was carried out using MACS microbeads coated with a specific monoclonal antibody (Miltenyi Biotec) as described previously [<xref rid="bib25" ref-type="bibr">25</xref>]. Subcellular fractions from mouse thymus were obtained as described previously [<xref rid="bib21" ref-type="bibr">21</xref>].</p>
      </sec>
      <sec id="sec0006">
        <label>2.4</label>
        <title>Cell culture and transfection</title>
        <p>Cell culture and transfection were performed as previously described [<xref rid="bib21" ref-type="bibr">21</xref>].</p>
      </sec>
      <sec id="sec0007">
        <label>2.5</label>
        <title>Immunoprecipitations and Western blotting</title>
        <p>Immunoprecipitations and Western blotting were performed as previously described [<xref rid="bib18" ref-type="bibr">18</xref>,<xref rid="bib21" ref-type="bibr">21</xref>].</p>
      </sec>
      <sec id="sec0008">
        <label>2.6</label>
        <title>Immunocytochemistry</title>
        <p>Immunostaining was performed as described previously [<xref rid="bib18" ref-type="bibr">18</xref>,<xref rid="bib21" ref-type="bibr">21</xref>].</p>
      </sec>
      <sec id="sec0009">
        <label>2.7</label>
        <title>Construction of plasmids</title>
        <p>The cDNAs encoding full-length human Tespa1 (residues 2â521) and its deletion mutants (residues 2â201 and 2â182) were cloned into the pCMV-HA vector (Clontech). Site-directed mutants of Tespa1 were generated by utilizing the KOD-Plus-Mutagenesis kit (TOYOBO). The GFP-tagged full-length mouse IP<sub>3</sub>R1 fusion protein and its deletion mutants were generated as described previously [<xref rid="bib21" ref-type="bibr">21</xref>]. The cDNA encoding IP<sub>3</sub>R1 deletion mutants (residues 611â2749, 2216â2749, 1â230 fused to 2216â2749, and 231â610 fused to 2216â2749) were cloned into the pEGFP-N1 vector (Clontech).</p>
      </sec>
    </sec>
    <sec id="sec0010">
      <label>3</label>
      <title>Results and discussion</title>
      <sec id="sec0011">
        <label>3.1</label>
        <title>Identification of Tespa1 as a KRAP-related protein</title>
        <p>To explore whether there are structurally and functionally KRAP-related proteins, we used the N-terminal amino acid sequences of KRAP (residues 1â203 of mouse KRAP or residues 1â201 of human KRAP) as the query sequences for the protein BLAST program (National Center for Biotechnology Information, <ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastHome" id="interref1">http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastHome</ext-link>), and this search revealed that the gene <italic>Tespa1</italic> encodes a KRAP-related protein (Supplementary data, <xref rid="sec0016" ref-type="sec">Fig. S1</xref>). NH<sub>2</sub>-terminal amino acid residues 1â300 of Tespa1, which are conserved between human and mouse species, showed 50% amino acid sequence similarity with those of KRAPs (Supplementary data, <xref rid="sec0016" ref-type="sec">Fig. S1</xref>).</p>
        <p>To examine the exact tissue distribution of the mouse Tespa1 protein, Western blot analysis and immunoprecipitation experiments for the Tespa1 protein in the adult mouse tissues were performed (<xref rid="fig0001" ref-type="fig">Fig. 1</xref>A). Strong expressions of the Tespa1 protein were detected in the thymus and spleen, but the protein was rarely detected in the other tissues when total tissue lysates were used as the samples for Western blotting (<xref rid="fig0001" ref-type="fig">Fig. 1</xref>A, top). Although weak expressions of the Tespa1 protein were also detected in the immunoprecipitates concentrated from lung and skeletal muscle by using anti-Tespa1 antibody (<xref rid="fig0001" ref-type="fig">Fig. 1</xref>A, bottom), <italic>Tespa1</italic> was found to encode an immune system-specific protein. Subsequently, we examined MACS-selected lymphocytes from the adult mouse spleen to determine the cell-type distribution of the Tespa1 protein. Among the lymphocytes isolated from the spleen, Tespa1 was detected in CD19<sup>+</sup>, CD4<sup>+</sup>, and CD8<sup>+</sup> lymphocytes, but undetectable in CD11b<sup>+</sup> lymphocytes (<xref rid="fig0001" ref-type="fig">Fig. 1</xref>B), demonstrating that the Tespa1 protein is predominantly expressed in B and T lymphocytes but not in other cell types, such as monocytes and macrophages in the spleen. These results are well-consistent with the previous data that mRNA expression of <italic>Tespa1</italic> is specifically detected in the lymphoid tissues, thymus, spleen, and lymph nodes, and is detectable in T and B lymphocytes, but not in macrophages [<xref rid="bib24" ref-type="bibr">24</xref>]. In addition, to examine the subcellular localization of the Tespa1 protein in the mouse thymus, we carried out a biochemical subcellular fractionation assay and showed that Tespa1 was exclusively detected in the P3, microsomal fraction, which was similar to the expression patterns for IP<sub>3</sub>R1 and IP<sub>3</sub>R3 proteins (<xref rid="fig0001" ref-type="fig">Fig. 1</xref>C). It is of note that KRAP was previously found to be also fractionated into the microsomal fraction prepared from the mouse liver [<xref rid="bib21" ref-type="bibr">21</xref>], which was probably due to the physical association of KRAP with IP<sub>3</sub>R on the endoplasmic reticulum membranes [<xref rid="bib21" ref-type="bibr">21</xref>]. Thus, these observations suggested the possibility that the Tespa1 protein may also bind to the lumen of the cytosolic side of the endoplasmic reticulum membranes by interacting with IP<sub>3</sub>R.</p>
      </sec>
      <sec id="sec0012">
        <label>3.2</label>
        <title>Tespa1 interacts with IP<sub>3</sub>R subtypes in T and B lymphocytes</title>
        <p>To examine whether Tespa1 interacts with IP<sub>3</sub>R, anti-Tespa1 immunoprecipitation and anti-IP<sub>3</sub>R3 immunoprecipitation experiments were performed using the mouse thymus or spleen, and the results showed that Tespa1 interacts with IP<sub>3</sub>R1 and IP<sub>3</sub>R3 (<xref rid="fig0002" ref-type="fig">Fig. 2</xref>A and B). In addition, co-immunoprecipitation studies using B220<sup>+</sup> lymphocytes, CD4<sup>+</sup> lymphocytes, a human T-cell leukemia line (Jurkat), and a mouse T-cell leukemia line (EL4) confirmed the association between Tespa1 and IP<sub>3</sub>Rs (<xref rid="fig0002" ref-type="fig">Fig. 2</xref>C and D). Furthermore, endogenous Tespa1 is well-colocalized with IP<sub>3</sub>R3 in Jurkat cells (<xref rid="fig0002" ref-type="fig">Fig. 2</xref>E). These results showed that the Tespa1 protein binds multiple subtypes of IP<sub>3</sub>R both in tissues and in cultured cells. It is of note that Tespa1 efficiently associated with both the subtype IP<sub>3</sub>R1 and the subtype IP<sub>3</sub>R3 in the thymus (<xref rid="fig0002" ref-type="fig">Fig. 2</xref>A), whereas Tespa1 preferentially associated with IP<sub>3</sub>R3 over IP<sub>3</sub>R1 in the spleen (<xref rid="fig0002" ref-type="fig">Fig. 2</xref>AâD).</p>
      </sec>
      <sec id="sec0013">
        <label>3.3</label>
        <title>Identification of the critical region of IP<sub>3</sub>R for the association with Tespa1</title>
        <p>To identify the critical region of IP<sub>3</sub>Rs for the association with Tespa1, we examined the interactions of several GFP-tagged IP<sub>3</sub>R1 deletion mutants (<xref rid="fig0003" ref-type="fig">Fig. 3</xref>A, MI-aâi) with the full-length HA-tagged Tespa1. The NH<sub>2</sub>-terminal amino acid residues 1â610, which were conserved among IP<sub>3</sub>R subtypes, bound to Tespa1, but the suppressor domain (MI-e) or ligand binding domain (MI-f) did not bind to Tespa1 (<xref rid="fig0003" ref-type="fig">Fig. 3</xref>B and C). These results indicate that amino acid residues 1â610 spanning over these two domains were necessary for the interaction with Tespa1 (<xref rid="fig0003" ref-type="fig">Fig. 3</xref>B and C). Because we previously reported that the interaction of IP<sub>3</sub>Rs with KRAP is also mediated by the NH<sub>2</sub>-terminal amino acid residues 1â610 of IP<sub>3</sub>Rs [<xref rid="bib21" ref-type="bibr">21</xref>], the molecular mechanism underlying the formations of the KRAPâIP<sub>3</sub>R complex and Tespa1âIP<sub>3</sub>R complex would be well-conserved.</p>
      </sec>
      <sec id="sec0014">
        <label>3.4</label>
        <title>Identification of the critical region of Tespa1 for the association with IP<sub>3</sub>R</title>
        <p>To determine the region of Tespa1 that is critical for the association with IP<sub>3</sub>R, we constructed several HA-tagged human Tespa1 deletion mutants (<xref rid="fig0004" ref-type="fig">Fig. 4</xref>A, MT-aâc) and examined their interaction with the full-length of GFP-tagged IP<sub>3</sub>R1. We found that the MT-b but not the MT-c interacts with IP<sub>3</sub>R1, indicating that a span of 19 amino acid residues (183â201) of human Tespa1 is essential for the interaction with IP<sub>3</sub>R1 (<xref rid="fig0004" ref-type="fig">Fig. 4</xref>B). Interestingly, this critical region is highly conserved between human and mouse Tespa1 as well as between human and mouse KRAP (<xref rid="fig0004" ref-type="fig">Fig. 4</xref>C). Because we previously found that two consecutive phenylalanine residues (Phe202/Phe203) in mouse KRAP are critical for the association of KRAP with IP<sub>3</sub>R [<xref rid="bib23" ref-type="bibr">23</xref>], we exchanged one or both phenylalanine residue(s) at positions 185 and 186 of human Tespa1 for alanine residues (<xref rid="fig0004" ref-type="fig">Fig. 4</xref>C), and compared the IP<sub>3</sub>R1-binding activity between the resulting proteins and the wild-type Tespa1 form. Neither the F185A/F186A mutant nor the F185A mutant bound with IP<sub>3</sub>R1, whereas the F186A mutant showed a weak interaction with IP<sub>3</sub>R1 (<xref rid="fig0004" ref-type="fig">Fig. 4</xref>D). Together, these results indicated that a common molecular base, in which two consecutive phenylalanine residues conserved among the KRAP and Tespa1 proteins are critical for the association with IP<sub>3</sub>Rs, underlies the formations of the KRAPâIP<sub>3</sub>R complex and Tespa1âIP<sub>3</sub>R complex.</p>
        <p>In this study, we identified Tespa1 as a structurally and functionally KRAP-related protein; Tespa1 has substantial homology to KRAP and is a novel binding partner of IP<sub>3</sub>Rs in T and B lymphocytes. Recently, Tespa1 was reported to play critical roles in the positive selection of thymocytes <italic>in vivo</italic> [<xref rid="bib24" ref-type="bibr">24</xref>], based on the analysis of <italic>Tespa1</italic>-deficient mice, and also suggested that Tespa1 is involved in the proper assembly of the Lat signalosome through its interaction with PLC-Î³1 and Grb2 [<xref rid="bib24" ref-type="bibr">24</xref>,<xref rid="bib26 bib27 bib28 bib29 bib30 bib31" ref-type="bibr">26â31</xref>]. This finding indicates the physiological significance of Tespa1 in T-cell antigen receptor signaling in the immune system. Here, we have clearly demonstrated that Tespa1 is a novel IP<sub>3</sub>R-interacting protein in T and B lymphocytes, and this finding would explain why the severe impairments of calcium flux in the <italic>Tespa1</italic>-deficient mice occur [<xref rid="bib24" ref-type="bibr">24</xref>]. Our finding is well-consistent with a recent hypothesis that Tespa1 participates in T-cell signaling through regulating calcium release from endoplasmic reticulum through interaction with IP<sub>3</sub>R, after interacting with the Lat signalosome [<xref rid="bib32" ref-type="bibr">32</xref>].</p>
        <p>Because Tespa1 is predominantly expressed both in T lymphocytes and in B lymphocytes, it is likely that Tespa1 would affect calcium signaling through the physical interaction with IP<sub>3</sub>R in B lymphocytes as well as T lymphocytes. Interestingly, Tespa1 appeared to preferentially interact with IP<sub>3</sub>R3 over IP<sub>3</sub>R1 in splenocytes (<xref rid="fig0002" ref-type="fig">Fig. 2</xref>AâD), whereas Tespa1 efficiently interacted with both the IP<sub>3</sub>R subtypes in the thymus (<xref rid="fig0002" ref-type="fig">Fig. 2</xref>A), suggesting that Tespa1 may interact with different subtypes of IP<sub>3</sub>R according to the cell-type and/or cellular status. If this is the case, the association between Tespa1 and distinct IP<sub>3</sub>R subtypes would play critical roles in the cell-type-specific and/or cellular status-specific biological processes in the lymphocytes.</p>
        <p>In conclusion, we identified Tespa1 as a novel binding partner of IP<sub>3</sub>R in the T and B lymphocytes, and these findings shed light on the molecular mechanism underlying calcium signaling through the regulation of IP<sub>3</sub>R in the immune system.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal" id="sbref1">
          <person-group person-group-type="author">
            <name>
              <surname>Berridge</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Lipp</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bootman</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>The versatility and universality of calcium signaling</article-title>
          <source>Nat. Rev. Mol. Cell Biol</source>
          <volume>1</volume>
          <year>2000</year>
          <fpage>11</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">11413485</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal" id="sbref2">
          <person-group person-group-type="author">
            <name>
              <surname>Berridge</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Inositol trisphosphate and calcium signalling mechanisms</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1793</volume>
          <year>2009</year>
          <fpage>933</fpage>
          <lpage>940</lpage>
          <pub-id pub-id-type="pmid">19010359</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal" id="sbref3">
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Danoff</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Schell</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Ullrich</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>89</volume>
          <year>1992</year>
          <fpage>4265</fpage>
          <lpage>4269</lpage>
          <pub-id pub-id-type="pmid">1374893</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal" id="sbref4">
          <person-group person-group-type="author">
            <name>
              <surname>Sharp</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>McPherson</surname>
              <given-names>P.S.</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>K.P.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca<sup>2+</sup> release channels in rat brain</article-title>
          <source>J. Neurosci</source>
          <volume>13</volume>
          <year>1993</year>
          <fpage>3051</fpage>
          <lpage>3063</lpage>
          <pub-id pub-id-type="pmid">8392539</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal" id="sbref5">
          <person-group person-group-type="author">
            <name>
              <surname>Sugiyama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yamamoto-Hino</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Miyawaki</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Furuichi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Mikoshiba</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Subtypes of inositol 1,4,5-trisphosphate receptor in human hematopoietic cell lines: dynamic aspects of their cell-type specific expression</article-title>
          <source>FEBS Lett</source>
          <volume>349</volume>
          <year>1994</year>
          <fpage>191</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="pmid">8050564</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal" id="sbref6">
          <person-group person-group-type="author">
            <name>
              <surname>Newton</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Mignery</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>SÃ¼dhof</surname>
              <given-names>T.C.</given-names>
            </name>
          </person-group>
          <article-title>Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP<sub>3</sub>) receptors with distinct affinities for InsP<sub>3</sub></article-title>
          <source>J. Biol. Chem</source>
          <volume>269</volume>
          <year>1994</year>
          <fpage>28613</fpage>
          <lpage>28619</lpage>
          <pub-id pub-id-type="pmid">7961809</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal" id="sbref7">
          <person-group person-group-type="author">
            <name>
              <surname>Wojcikiewicz</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types</article-title>
          <source>J. Biol. Chem</source>
          <volume>270</volume>
          <year>1995</year>
          <fpage>11678</fpage>
          <lpage>11683</lpage>
          <pub-id pub-id-type="pmid">7744807</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal" id="sbref8">
          <person-group person-group-type="author">
            <name>
              <surname>Jayaraman</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>OndriasovÃ¡</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ondrias</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Harnick</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>A.R.</given-names>
            </name>
          </person-group>
          <article-title>The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>92</volume>
          <year>1995</year>
          <fpage>6007</fpage>
          <lpage>6011</lpage>
          <pub-id pub-id-type="pmid">7597070</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal" id="sbref9">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Soloski</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Sharp</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Schilling</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sabatini</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor</article-title>
          <source>Science</source>
          <volume>273</volume>
          <year>1996</year>
          <fpage>503</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">8662540</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal" id="sbref10">
          <person-group person-group-type="author">
            <name>
              <surname>Sugawara</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kurosaki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Takata</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kurosaki</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor</article-title>
          <source>EMBO J.</source>
          <volume>16</volume>
          <year>1997</year>
          <fpage>3078</fpage>
          <lpage>3088</lpage>
          <pub-id pub-id-type="pmid">9214625</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal" id="sbref11">
          <person-group person-group-type="author">
            <name>
              <surname>Scharenberg</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Humphries</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Rawlings</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>Calcium signalling and cell-fate choice in B cells</article-title>
          <source>Nat. Rev. Immunol.</source>
          <volume>7</volume>
          <year>2007</year>
          <fpage>778</fpage>
          <lpage>789</lpage>
          <pub-id pub-id-type="pmid">17853903</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal" id="sbref12">
          <person-group person-group-type="author">
            <name>
              <surname>deSouza</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dura</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>T.V.</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>A.R.</given-names>
            </name>
          </person-group>
          <article-title>A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation</article-title>
          <source>J. Cell Biol.</source>
          <volume>179</volume>
          <year>2007</year>
          <fpage>923</fpage>
          <lpage>934</lpage>
          <pub-id pub-id-type="pmid">18056410</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal" id="sbref13">
          <person-group person-group-type="author">
            <name>
              <surname>Patterson</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Boehning</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Inositol 1,4,5-trisphosphate receptors as signal integrators</article-title>
          <source>Annu. Rev. Biochem</source>
          <volume>73</volume>
          <year>2004</year>
          <fpage>437</fpage>
          <lpage>465</lpage>
          <pub-id pub-id-type="pmid">15189149</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal" id="sbref14">
          <person-group person-group-type="author">
            <name>
              <surname>Bezprozvanny</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>The inositol 1,4,5-trisphosphate receptors</article-title>
          <source>Cell Calcium</source>
          <volume>38</volume>
          <year>2005</year>
          <fpage>261</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="pmid">16102823</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal" id="sbref15">
          <person-group person-group-type="author">
            <name>
              <surname>Foskett</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Mak</surname>
              <given-names>D.O.</given-names>
            </name>
          </person-group>
          <article-title>Inositol trisphosphate receptor Ca<sup>2+</sup> release channels</article-title>
          <source>Physiol. Rev</source>
          <volume>87</volume>
          <year>2007</year>
          <fpage>593</fpage>
          <lpage>658</lpage>
          <pub-id pub-id-type="pmid">17429043</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal" id="sbref16">
          <person-group person-group-type="author">
            <name>
              <surname>Mikoshiba</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>IP<sub>3</sub> receptor/Ca<sup>2+</sup> channel: from discovery to new signaling concepts</article-title>
          <source>J. Neurochem.</source>
          <volume>102</volume>
          <year>2007</year>
          <fpage>1426</fpage>
          <lpage>1446</lpage>
          <pub-id pub-id-type="pmid">17697045</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal" id="sbref17">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fritz</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ibarra</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>UhlÃ©n</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations</article-title>
          <source>Neurochem. Res.</source>
          <volume>36</volume>
          <year>2011</year>
          <fpage>1175</fpage>
          <lpage>1185</lpage>
          <pub-id pub-id-type="pmid">21479917</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal" id="sbref18">
          <person-group person-group-type="author">
            <name>
              <surname>Fujimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Koyanagi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Baba</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Nakabayashi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sasazuki</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line</article-title>
          <source>J. Hum. Genet</source>
          <volume>52</volume>
          <year>2007</year>
          <fpage>978</fpage>
          <lpage>984</lpage>
          <pub-id pub-id-type="pmid">17934691</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal" id="sbref19">
          <person-group person-group-type="author">
            <name>
              <surname>Fujimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Miyasaka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Koyanagi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tsunoda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Baba</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice</article-title>
          <source>PLoS One</source>
          <volume>4</volume>
          <year>2009</year>
          <fpage>e4240</fpage>
          <pub-id pub-id-type="pmid">19156225</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal" id="sbref20">
          <person-group person-group-type="author">
            <name>
              <surname>Miyasaka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kawanami</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Takiguchi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jimi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Funakoshi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Pancreatic hypertrophy in Ki-ras-induced actin-interacting protein gene knockout mice</article-title>
          <source>Pancreas</source>
          <volume>40</volume>
          <year>2011</year>
          <fpage>79</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">21160370</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal" id="sbref21">
          <person-group person-group-type="author">
            <name>
              <surname>Fujimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Machida</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tsunoda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
            <name>
              <surname>Shirasawa</surname>
              <given-names>.</given-names>
            </name>
          </person-group>
          <article-title>KRAS-induced actin-interacting protein is required for the proper localization of inositol 1,4,5-trisphosphate receptor in the epithelial cells</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>407</volume>
          <year>2011</year>
          <fpage>438</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="pmid">21420385</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal" id="sbref22">
          <person-group person-group-type="author">
            <name>
              <surname>Fujimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Machida</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tsunoda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kuroki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>KRAS-induced actin-interacting protein regulates inositol 1,4,5-trisphosphate-receptor-mediated calcium release</article-title>
          <source>Biochem. Biophys. Res. Commun</source>
          <volume>408</volume>
          <year>2011</year>
          <fpage>214</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="pmid">21457704</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal" id="sbref23">
          <person-group person-group-type="author">
            <name>
              <surname>Fujimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Machida</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tsunoda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kuroki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Determination of the critical region of KRAS-induced actin-interacting protein for the interaction with inositol 1,4,5-trisphosphate receptor</article-title>
          <source>Biochem. Biophys. Res. Commun</source>
          <volume>408</volume>
          <year>2011</year>
          <fpage>282</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">21501587</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal" id="sbref24">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Tespa1 is involved in late thymocyte development through the regulation of TCR-mediated signaling</article-title>
          <source>Nat. Immunol</source>
          <volume>13</volume>
          <year>2012</year>
          <fpage>560</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="pmid">22561606</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal" id="sbref25">
          <person-group person-group-type="author">
            <name>
              <surname>Koyanagi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nakabayashi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Baba</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Takashima</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>ZFAT expression in B and T lymphocytes and identification of ZFAT-regulated genes</article-title>
          <source>Genomics</source>
          <volume>91</volume>
          <year>2008</year>
          <fpage>451</fpage>
          <lpage>457</lpage>
          <pub-id pub-id-type="pmid">18329245</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal" id="sbref26">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Aravind</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Shulzhenko</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Morgun</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Crockford</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Themis is a member of a new metazoan gene family and is required for the completion of thymocyte positive selection</article-title>
          <source>Nat. Immunol</source>
          <volume>10</volume>
          <year>2009</year>
          <fpage>831</fpage>
          <lpage>839</lpage>
          <pub-id pub-id-type="pmid">19597497</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal" id="sbref27">
          <person-group person-group-type="author">
            <name>
              <surname>Lesourne</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Uehara</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Pinkhasov</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Themis, a T cell-specific protein important for late thymocyte development</article-title>
          <source>Nat. Immunol</source>
          <volume>10</volume>
          <year>2009</year>
          <fpage>840</fpage>
          <lpage>847</lpage>
          <pub-id pub-id-type="pmid">19597498</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal" id="sbref28">
          <person-group person-group-type="author">
            <name>
              <surname>Fu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>VallÃ©e</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rybakin</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>McGuire</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Ampudia</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Brockmeyer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling</article-title>
          <source>Nat. Immunol</source>
          <volume>10</volume>
          <year>2009</year>
          <fpage>848</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="pmid">19597499</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal" id="sbref29">
          <person-group person-group-type="author">
            <name>
              <surname>Patrick</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Oda</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hayakawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Eshima</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kirikae</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Gasp, a Grb2-associating protein, is critical for positive selection of thymocytes</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>106</volume>
          <year>2009</year>
          <fpage>16345</fpage>
          <lpage>16350</lpage>
          <pub-id pub-id-type="pmid">19805304</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal" id="sbref30">
          <person-group person-group-type="author">
            <name>
              <surname>Kakugawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yasuda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fukiage</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Satoh</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>A novel gene essential for the development of single positive thymocytes</article-title>
          <source>Mol. Cell Biol.</source>
          <volume>29</volume>
          <year>2009</year>
          <fpage>5128</fpage>
          <lpage>5135</lpage>
          <pub-id pub-id-type="pmid">19620281</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal" id="sbref31">
          <person-group person-group-type="author">
            <name>
              <surname>Brockmeyer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Paster</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Pepper</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Trudgian</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>McGowan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>6et</surname>
              <given-names>al</given-names>
            </name>
          </person-group>
          <article-title>T cell receptor (TCR)-induced tyrosine phosphorylation dynamics identifies THEMIS as a new TCR signalosome component</article-title>
          <source>J. Biol. Chem.</source>
          <volume>286</volume>
          <year>2011</year>
          <fpage>7535</fpage>
          <lpage>7547</lpage>
          <pub-id pub-id-type="pmid">21189249</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <element-citation publication-type="journal" id="sbref32">
          <person-group person-group-type="author">
            <name>
              <surname>Gascoigne</surname>
              <given-names>NR.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Tespa1: another gatekeeper for positive selection</article-title>
          <source>Nat. Immunol</source>
          <volume>13</volume>
          <year>2012</year>
          <fpage>530</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="pmid">22610243</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="sec0016" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>
        <supplementary-material content-type="local-data" id="ec1">
          <caption>
            <title>Fig. S1</title>
            <p>Human Tespa1, mouse Tespa1, human KRAP, and mouse KRAP protein sequences aligned using Clustal W program (<ext-link ext-link-type="uri" xlink:href="http://www.genome.jp/tools/clustalw/" id="interref3">http://www.genome.jp/tools/clustalw/</ext-link>). The degree of conservation is denoted by the following symbols: â*â (identical in all sequences), â:â (conserved substitutions), and â.â (semiconserved substitutions).</p>
          </caption>
          <media xlink:href="mmc1.doc" mimetype="application" mime-subtype="msword"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was supported in part by the <funding-source id="GS1">Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities</funding-source>, a Grant-in-Aid for Young Scientists (B) Grant No. 24710265. This work was supported in part by funds (No. 112503) from the Central Research Institute of Fukuoka University. We thank Takami Danno, Aya Fujikane and Yuka Horio for their technical assistance.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig0001">
      <label>Fig. 1</label>
      <caption>
        <p>Tespa1 protein exists in the microsomal fraction in lymphocytes. (A) Western blot analysis and immunoprecipitations by using anti-Tespa1 antibody for Tespa1 protein expression in the 12 kinds of adult mouse tissues. ERK is used as a loading control. WAT, white adipose tissue. (B) Western blot analysis for Tespa1 protein expression in CD19<sup>+</sup>, CD4<sup>+</sup>, CD8<sup>+</sup>, and CD11b<sup>+</sup> cells isolated from the adult mouse spleen. Actin is used as a loading control. (C) Western blot analysis of Tespa1, IP<sub>3</sub>R1, IP<sub>3</sub>R3, ATP synthase (ATP syn), and actin expressions in the subcellular fractions from the adult mouse thymus. S3, soluble cytoplasmic fraction; P2, crude mitochondrial fraction; P3, crude microsomal fraction; total, total lysate; IP, immunoprecipitations.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig0002">
      <label>Fig. 2</label>
      <caption>
        <p>Physical association of Tespa1 with IP<sub>3</sub>R subtypes. (A) Immunoprecipitations with anti-Tespa1 (Î±Tespa1) or control (preimmune) antibodies were performed using the mouse thymus or spleen, followed by Western blotting with anti-Tespa1, anti-IP<sub>3</sub>R1, or anti-IP<sub>3</sub>R3 antibodies. (B) Immunoprecipitations with IP<sub>3</sub>R3 (Î±IP<sub>3</sub>R3) or control (Ctl.IgG) antibodies were performed using the mouse thymus or spleen, followed by Western blotting with anti-Tespa1 or anti-IP<sub>3</sub>R1 antibodies. (C and D) Immunoprecipitations with anti-Tespa1 (Î±Tespa1) or control (preimmune) antibodies were performed using B220<sup>+</sup>âB lymphocytes or CD4<sup>+</sup>âT lymphocytes isolated from the adult mouse spleen (C), or using T-cell leukemia lines, Jurkat or EL4 (D), followed by Western blotting with anti-Tespa1, anti-IP<sub>3</sub>R1, or anti-IP<sub>3</sub>R3 antibodies. IP, Immunoprecipitations; total, total lysate. (E) Confocal immunostaining with anti-Tespa1 and anti-IP<sub>3</sub>R3 antibodies in Jurkat cells. Blue, 4â²,6-Diamidino-2-phenylindole (DAPI) staining. Scale bar, 15 Î¼m. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig0003">
      <label>Fig. 3</label>
      <caption>
        <p>Critical region of IP<sub>3</sub>R for the association with Tespa1. (A) A schematic illustration of the functional domains of mouse IP<sub>3</sub>R1 (top) and GFP-tagged IP<sub>3</sub>R1-deletion mutants used in this study (bottom). Black ribbon is shown for IP<sub>3</sub>R1 sequence. Hatched ribbon is shown for IP<sub>3</sub>R3 sequence. (B and C) Co-immunoprecipitations using full-length HA-tagged Tespa1 and deletion mutants of IP<sub>3</sub>R1. a.a., amino acids; IP, immunoprecipitations; total, total lysate.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig0004">
      <label>Fig. 4</label>
      <caption>
        <p>Critical region of Tespa1 for the association with IP<sub>3</sub>R. (A) A schematic illustration of human Tespa1 (top) and HA-tagged Tespa1-deletion mutants used in this study (bottom). (B) Co-immunoprecipitations using full-length IP<sub>3</sub>R1 and deletion mutants of Tespa1. (C) The critical region of Tespa1 required for the IP<sub>3</sub>R interaction (top). Double or single amino acid substitutions from phenylalanine to alanine residue(s) within human Tespa1 (bottom). (D) Co-immunoprecipitations using full-length IP<sub>3</sub>R and various mutants of Tespa1 (C). a.a., amino acids; IP, immunoprecipitations; total, total lysate.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>